Semiparametric analysis of non-steady-state pharmacodynamic data
暂无分享,去创建一个
[1] L. Sheiner,et al. Pharmacodynamic modeling of verapamil effects under steady-state and nonsteady-state conditions. , 1989, The Journal of pharmacology and experimental therapeutics.
[2] R. Mcquinn,et al. The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: Effects on cardiac function and drug clearance , 1989, Clinical pharmacology and therapeutics.
[3] K. Simons,et al. The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine. , 1984, The Journal of allergy and clinical immunology.
[4] Carl de Boor,et al. A Practical Guide to Splines , 1978, Applied Mathematical Sciences.
[5] L B Sheiner,et al. Simultaneous Modeling of Pharmacokinetics and Pharmacodynamics with a Nonparametric Pharmacodynamic Model , 1984, Clinical pharmacology and therapeutics.
[6] G. Segre,et al. Kinetics of interaction between drugs and biological systems. , 1968, Il Farmaco; edizione scientifica.
[7] Lewis B. Sheiner,et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: an improved algorithm , 1987, Comput. Appl. Biosci..
[8] Douglas M. Bates,et al. Nonlinear Regression Analysis and Its Applications , 1988 .
[9] A Sibbald,et al. A pharmacodynamic model for pancuronium. , 1978, British journal of anaesthesia.
[10] V. F. Smolen. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures , 1976, Journal of Pharmacokinetics and Biopharmaceutics.
[11] H. Akaike. A new look at the statistical model identification , 1974 .
[12] Peter Veng-Pedersen,et al. Estimation of amobarbital plasma-effect site equilibration kinetics. Relevance of polyexponential conductance functions , 1991, Journal of Pharmacokinetics and Biopharmaceutics.
[13] L B Sheiner,et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models , 1986, Clinical pharmacology and therapeutics.
[14] V. F. Smolen. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input ⇄ response relationships , 1976, Journal of Pharmacokinetics and Biopharmaceutics.
[15] D. Campbell. The use of kinetic-dynamic interactions in the evaluation of drugs , 2005, Psychopharmacology.
[16] L. Sheiner. Clinical pharmacology and the choice between theory and empiricism , 1989, Clinical pharmacology and therapeutics.
[17] Lewis B. Sheiner,et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine , 1979 .
[18] P. Veng‐Pedersen,et al. A system approach to pharmacodynamics. I: Theoretical framework. , 1988, Journal of pharmaceutical sciences.
[19] L B Sheiner,et al. Semiparametric approach to pharmacokinetic-pharmacodynamic data. , 1989, The American journal of physiology.
[20] C. R. Deboor,et al. A practical guide to splines , 1978 .
[21] E. H. Twizell. The mathematical modeling of metabolic and endocrine systems: E.R. Carson, C. Cobelli and L. Finkelstein John Wiley and Sons, Chichester, Sussex, UK, 394 pp., £45.15, 1983 , 1984 .
[22] L B Sheiner,et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. , 1980, Clinical pharmacology and therapeutics.
[23] M Danhof,et al. A system approach to pharmacodynamics. III: An algorithm and computer program, COLAPS, for pharmacodynamic modeling. , 1991, Journal of pharmaceutical sciences.